EMA Reviewing Guide To Support New Genome Editing Technologies, CAR-T Cell Therapies

 
• By Vibha Sharma

The European Medicines Agency is updating its five-year old guideline on drugs containing genetically modified cells to factor in rapid scientific developments in relation to gene editing technologies, and the development of promising new cancer immunotherapies, such as CAR-T cells.

CRISPR
EMA Is Reviewing Its Guidance To Keep Pace With New Genome Editing Technologies • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies